Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network. [electronic resource]
Producer: 20101207Description: 1834-1838 p. digitalISSN:- 1569-8041
- Adolescent
- Adult
- Antineoplastic Agents -- therapeutic use
- Antiviral Agents -- therapeutic use
- Basic Helix-Loop-Helix Leucine Zipper Transcription Factors -- genetics
- Benzenesulfonates -- therapeutic use
- Carcinoma, Renal Cell -- drug therapy
- Child
- Child, Preschool
- Chromosomes, Human, Pair 11 -- genetics
- Chromosomes, Human, X -- genetics
- Everolimus
- Female
- Gene Fusion
- Humans
- Immunosuppressive Agents -- therapeutic use
- Indoles -- therapeutic use
- Interferon-alpha -- therapeutic use
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Pyridines -- therapeutic use
- Pyrroles -- therapeutic use
- Research Report
- Retrospective Studies
- Sirolimus -- analogs & derivatives
- Sorafenib
- Sunitinib
- Survival Rate
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Translocation, Genetic -- genetics
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.